Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  EntreMed Inc       US29382F2020

SummaryNewsCalendarCompany 
Business Summary
Develops pharmaceutical drugs for treating cancer & inflammatory diseases

CASI Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company developing a new generation of multi-mechanism drugs for the treatment of cancer and inflammatory diseases.

Its drug candidate, ENMD 2076, which is an Aurora A and angiogenic kinase inhibitor for the treatment of cancer.

The company was founded in 1991 and is headquartered in Rockville, MD.

Number of employees : 16 persons.
Sales per Businesses
20122013Delta
USD (in Million)%USD (in Million)%
Therapeutics0.669100%---
Sales per Regions
20122013Delta
USD (in Million)%USD (in Million)%
United States0.669100%---
Managers
NameAgeSinceTitle
Ken Keyong Ren MD, PhD552012Chief Executive Officer & Director
Wei-Wu He PhD, MBA492012Executive Chairman
Cynthia Wong Hu442006COO, Secretary, Vice President & General Counsel
Sara B. Capitelli, CPA442011Chief Accounting Officer & Vice President-Finance
William E. Gannon Jr., MD-2012Vice President-Medical & Regulatory Affairs
Jennie C. Hunter-Cevera, PhD662001Independent Director
Tak W. Mak, PhD672012Director
James Z. Huang, MBA482013Independent Director
Yue Alexander Wu PhD, MBA502013Independent Director
Franklin Cary Salisbury, Jr.-2014Director
Shareholders
NameShares%
IDG Capital Partners Co., Ltd. 6,842,783 21.1%
Spectrum Pharmaceuticals, Inc. 5,405,382 16.7%
Celgene Corp. 2,464,987 7.60%
Wellington Shields Capital Management LLC 851,705 2.63%
Sabby Capital LLC 788,485 2.43%
Wellington Shields & Co. LLC 518,583 1.60%
Emerging Technology Partners LLC 441,072 1.36%
Kleiner Perkins Caufield & Byers LLC 416,666 1.28%
The Vanguard Group, Inc. 400,060 1.23%
Tak W. Mak, PhD 365,376 1.13%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Biotechnology & Medical Research - NEC
Advertisement
Sector Biotechnology & Medical Research
Growth (Revenue) Profitability
PHARMACYCLICS, IN..
INCYTE CORPORATIO..
ALKERMES PLC
ALNYLAM PHARMACEU..
QUINTILES TRANSNA..
UNITED THERAPEUTI..
ISIS PHARMACEUTIC..
PUMA BIOTECHNOLOG..
-
CELLTRION, INC.
QIAGEN NV
INTREXON CORP
SEATTLE GENETICS,..
ICON PLC
PAREXEL INTERNATI..
CHARLES RIVER LAB..
BIO-TECHNE CORP
BB BIOTECH AG
-
SYNAGEVA BIOPHARM..
ACADIA PHARMACEUT..
WUXI PHARMATECH (..
Sector Biotechnology & Medical Research
EntreMed Inc : Connections
Crown Bioscience, Inc.
OriGene Technologies, Inc.
University of Toronto
Intradigm Corp.
Miikana Therapeutics, Inc.
Amnis Corp.
National Academy of Sciences
MithraGen, Inc.
Cytomyx Holdings Plc
Emerging Technology Partners LLC
The Campbell Family Institute for Breast Cancer Research
The Foundation For Sickle Cell Research
American Academy of Arts & Sciences
ImmunoVentis, Inc.
Wuhan Kindstar Diagnostics Co., Ltd.
Capital City Technical Consulting, Inc.
National Foundation for Cancer Research
Company contact information
CASI Pharmaceuticals, Inc.
9620 Medical Center Drive
Suite 300
Rockville, MD 20850

Phone : +1.240.864.2600
Fax : +1.240.315.2437
Web : www.casipharmaceuticals.com
© 2015 People , Fundamentals and Ownership   
Dynamic quotes  
ON
| OFF